Jul 09, 2020 8:19am EDT Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe
Jun 17, 2020 7:30am EDT Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
Jun 11, 2020 7:30am EDT Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress
Jun 03, 2020 7:30am EDT Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress
May 05, 2020 4:01pm EDT Rigel Reports First Quarter 2020 Financial Results and Provides Business Update
May 01, 2020 7:30am EDT Rigel Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
Apr 27, 2020 7:30am EDT Rigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business Update
Feb 27, 2020 4:01pm EST Rigel Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Feb 20, 2020 7:30am EST Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results
